DD206994A5 - Verfahren zur herstellung von pyridinderivaten - Google Patents

Verfahren zur herstellung von pyridinderivaten Download PDF

Info

Publication number
DD206994A5
DD206994A5 DD83248919A DD24891983A DD206994A5 DD 206994 A5 DD206994 A5 DD 206994A5 DD 83248919 A DD83248919 A DD 83248919A DD 24891983 A DD24891983 A DD 24891983A DD 206994 A5 DD206994 A5 DD 206994A5
Authority
DD
German Democratic Republic
Prior art keywords
group
general formula
compound
compounds
radicals
Prior art date
Application number
DD83248919A
Other languages
German (de)
English (en)
Inventor
David G Cooper
George S Sach
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DD206994A5 publication Critical patent/DD206994A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/58—Amidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD83248919A 1982-03-17 1983-03-17 Verfahren zur herstellung von pyridinderivaten DD206994A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8207835 1982-03-17
GB8209540 1982-03-31

Publications (1)

Publication Number Publication Date
DD206994A5 true DD206994A5 (de) 1984-02-15

Family

ID=26282275

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83248919A DD206994A5 (de) 1982-03-17 1983-03-17 Verfahren zur herstellung von pyridinderivaten

Country Status (17)

Country Link
US (3) US4551466A (el)
EP (2) EP0089765A3 (el)
AU (2) AU1254183A (el)
CA (1) CA1192191A (el)
DD (1) DD206994A5 (el)
DE (1) DE3366369D1 (el)
DK (2) DK123183A (el)
ES (1) ES520709A0 (el)
FI (1) FI830891L (el)
GR (2) GR77155B (el)
IL (1) IL68130A0 (el)
JO (1) JO1244B1 (el)
NO (1) NO830932L (el)
PL (1) PL241052A1 (el)
PT (1) PT76395B (el)
RO (1) RO85384B (el)
ZW (1) ZW6883A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
DK1394150T3 (da) 1999-02-24 2011-03-21 Hoffmann La Roche 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
CN1972914A (zh) 2004-03-31 2007-05-30 詹森药业有限公司 作为组胺h3受体配合体的非咪唑杂环化合物
SI1928427T1 (sl) 2005-09-23 2010-03-31 Hoffmann La Roche Nove formulacije za doziranje
KR101372941B1 (ko) 2006-05-30 2014-03-14 얀센 파마슈티카 엔.브이. 히스타민 ｈ３ 수용체 조절제로서의 치환된 피리딜 아미드 화합물
BRPI0820481A2 (pt) 2007-11-20 2015-06-16 Janssen Pharmaceutica Nv Composotos cicloalquilóxi e heterocicloalquilóxi piridina como moduladores do receptor de h3 de histamina
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
DE3070073D1 (en) * 1979-10-22 1985-03-14 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
US4410523A (en) * 1979-10-22 1983-10-18 Glaxo Group Limited Heterocyclic derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors

Also Published As

Publication number Publication date
EP0089153B1 (en) 1986-09-24
AU1254283A (en) 1983-09-22
RO85384B (ro) 1984-11-30
ZW6883A1 (en) 1983-06-08
ES8500935A1 (es) 1984-11-01
FI830891A7 (fi) 1983-09-18
PL241052A1 (en) 1984-05-21
EP0089153A2 (en) 1983-09-21
CA1192191A (en) 1985-08-20
AU1254183A (en) 1983-09-22
JO1244B1 (en) 1985-04-20
PT76395A (en) 1983-04-01
PT76395B (en) 1985-12-05
DK123083D0 (da) 1983-03-17
ES520709A0 (es) 1984-11-01
NO830932L (no) 1983-09-19
DK123183D0 (da) 1983-03-17
FI830891A0 (fi) 1983-03-17
DK123083A (da) 1983-09-18
IL68130A0 (en) 1983-06-15
DE3366369D1 (en) 1986-10-30
EP0089765A3 (en) 1984-05-23
DK123183A (da) 1983-09-18
EP0089765A2 (en) 1983-09-28
RO85384A (ro) 1984-11-25
GR77155B (el) 1984-09-07
US4574126A (en) 1986-03-04
US4758576A (en) 1988-07-19
FI830891L (fi) 1983-09-18
EP0089153A3 (en) 1984-07-11
GR77162B (el) 1984-09-10
US4551466A (en) 1985-11-05

Similar Documents

Publication Publication Date Title
DE69837675T2 (de) Pyrazolderivate
AU597696B2 (en) Benzimidazole derivatives
DE3873127T2 (de) Therapeutische praeparate.
DE69212870T2 (de) 4-Aryl-thiazole oder imidazolederivate
DE3433327A1 (de) 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)alkyl)piperazinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
CH649539A5 (de) Antidepressiv wirksame piperazinylalkyl-1,2,4-triazol-3-one.
CH647767A5 (de) Triazolverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DD211340A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
EP0335381A1 (de) Neue 2,3,4-substituierte Imidazole und 3,4,5-substituierte 1,2,4-Triazole, ihre Herstellung und Verwendung
DE2928842A1 (de) Pyrimidonderivate
DE2835695A1 (de) Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
EP0129791A2 (de) Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0772593B1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
DD202293A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
CH645892A5 (de) Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel.
DE4036645A1 (de) Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
DE3601143A1 (de) Cyclische imidderivate von 2-(4-butylpiperazin-1-yl)-pyridinen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3107628A1 (de) Heterocyclische derivate
DE3615180A1 (de) Disubstituierte 1,4-piperazinylderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE60107586T2 (de) Substituierte imidazole als duale histamine h1 und h3 agonisten oder antagonisten
DE3802362A1 (de) Tetrahydrofuranderivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
DE2717415A1 (de) Verfahren zur herstellung von phenylpiperazinderivaten, phenylpiperazinderivate und diese enthaltende pharmazeutische zubereitungen
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten